SOD1 and amyotrophic lateral sclerosis: In this study, we investigated the effects of tofersen treatment in patients with SOD1-ALS for the first time in a “real-world” setting, i.e., including and analyzing all SOD1 patients independent from the VALOR inclusion/exclusion criteria.